Skip to main content
. Author manuscript; available in PMC: 2022 May 9.
Published in final edited form as: ACS Infect Dis. 2021 Apr 23;7(6):1795–1808. doi: 10.1021/acsinfecdis.1c00101

Figure 7.

Figure 7.

Systemic efficacy of C10-KR8d in neutropenic mice infected with 2×106 CFU of S. aureus USA300 LAC. Two hours post infection, the peptide group was treated (i.p., 5 mg/kg, n = 8) with a single dose of C10-KR8d while the control infected group was untreated. The CFU difference is significant when p value < 0.05 and ns represents no significance. The statistics was determined using Mann-Whitney test in the GraphPad Prism 7.0.